Literature DB >> 9715834

Non-NSAID pharmacologic treatment options for the management of chronic pain.

T J Schnitzer1.   

Abstract

Chronic pain affects 75 million US citizens. A number of pharmacologic treatments are available for chronic pain that does not respond adequately to nonpharmacologic methods. Long the mainstay of chronic pain management, nonsteroidal anti-inflammatory drugs (NSAIDs) are known to be associated with gastrointestinal (GI) and renal toxicities, a particular problem for the elderly population, which commonly experiences chronic pain, such as that associated with osteoarthritis (OA). Several non-NSAID, non-narcotic therapies are available for noninflammatory pain. Acetaminophen is as effective as NSAIDs for the management of mild-to-moderate OA pain and is the recommended first-line therapy by the American College of Rheumatology (ACR). Propoxyphene, widely believed to be safe and effective, may, in fact, be no more effective-and perhaps less effective-than acetaminophen or ibuprofen. A relatively new analgesic, tramadol, appears to be a useful therapy for patients who do not receive adequate pain relief with acetaminophen and are at risk for NSAID-related side effects. For localized chronic pain associated with OA, topical capsaicin is also an effective analgesic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715834     DOI: 10.1016/s0002-9343(98)00073-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Dextropropoxyphene: safety and efficacy in older patients.

Authors:  David J Goldstein; Dennis C Turk
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Use of opioid medications for chronic noncancer pain syndromes in primary care.

Authors:  M Carrington Reid; Laura L Engles-Horton; MaryAnn B Weber; Robert D Kerns; Elizabeth L Rogers; Patrick G O'Connor
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

3.  Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.

Authors:  Maria G Sciulli; Francesca Seta; Stefania Tacconelli; Marta L Capone; Emanuela Ricciotti; Giuseppa Pistritto; Paola Patrignani
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

4.  Perforated peptic ulcer and short-term mortality among tramadol users.

Authors:  Marie L Tørring; Anders Riis; Steffen Christensen; Reimar W Thomsen; Peter Jepsen; Jens Søndergaard; Henrik T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

5.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

6.  How to approach the problem of low back pain: an overview.

Authors:  Munir J Nasser
Journal:  J Family Community Med       Date:  2005-01

7.  Mixture of Arnebia euchroma and Matricaria chamomilla (Marhame-Mafasel) for pain relief of osteoarthritis of the knee - a two-treatment, two-period crossover trial.

Authors:  Ali Reza Soltanian; Dariush Mehdibarzi; Soghrat Faghihzadeh; Mohsen Naseri; Abbas Gerami
Journal:  Arch Med Sci       Date:  2010-12-29       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.